FOLLITROPIN BETA belongs to a group of medicines called Gonadotropins. It is used to treat infertility in women (oligo-anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure) and to stimulate sperm production in men with hypogonadotropic hypogonadism.
FOLLITROPIN BETA contains Follitropin Beta, which helps to develop eggs in the ovaries of women and sperm in the testes of men.
FOLLITROPIN BETA may cause certain side effects, such as headache, vomiting, diarrhoea, abdominal cramps, abdominal pain, fever, sore throat, sneezing, and pain at the injection site. These side effects are usually mild and temporary. FOLLITROPIN BETA will be administered by a trained healthcare doctor.
Before receiving FOLLITROPIN BETA, inform your doctor if you have a known allergy to FOLLITROPIN BETA or any contents present in it. FOLLITROPIN BETA is not recommended for patients with primary ovarian failure, and primary testicular failure, pregnant and breastfeeding women. Inform your doctor about your complete medical and medication history before receiving FOLLITROPIN BETA to rule out any side effects.
Female infertility, Hypogonadism.
FOLLITROPIN BETA contains Follitropin Beta, which is used to treat fertility problems (usually given along with other medicines). In females, FOLLITROPIN BETA develops and ripens several follicles (containing eggs necessary for fertilization) in women undergoing assisted reproductive technologies (a procedure that helps to get pregnant). It also helps to induce the ovulation procedure (releasing an egg from the ovary). In males, it helps replenish the deficient testosterone (anabolic steroid and primary sex hormone in males) levels and helps produce sperm cells.
Headache
Abdominal pain
Diarrhoea
Pain or redness at the injection site
Nausea
Vomiting
Sudden weight gain
Difficulty breathing
Fever
Sore throat
Acne
Snuffy nose
Before receiving FOLLITROPIN BETA, inform your doctor if you have any known allergies to this medicine or any contents present in it. Also, inform your doctor about your complete medical and medication history before receiving FOLLITROPIN BETA to rule out any side effects. FOLLITROPIN BETA is not recommended for patients with primary ovarian failure, primary testicular failure, an untreated or uncontrolled disorder of the thyroid gland, pituitary gland, or adrenal gland, abnormal vaginal bleeding, ovarian cyst, breast cancer, uterine cancer, and cancer of ovaries, testicle, hypothalamus, or pituitary gland. Inform your doctor about your complete medical and medication history before receiving FOLLITROPIN BETA to rule out any side effects. Inform your doctor if you have/had any history of stroke, blood clot, stomach surgery, unusual vaginal bleeding, PCOD, and liver/kidney disease. This medicine is contraindicated in pregnant women, breastfeeding mothers and children.
Drug-Drug Interactions: FOLLITROPIN BETA interacts with certain medications used in fertility treatment to prevent premature ovulation (e.g. ganirelix).
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: FOLLITROPIN BETA potentially interacts with various disease conditions such as adrenal dysfunction, thyroid dysfunction, ovarian cysts (fluid-filled sacs in ovaries), and tumours of ovaries, womb, or breast.
It is unknown whether FOLLITROPIN BETA interacts with alcohol. However, as a precautionary measure, it is advisable not to take or limit alcohol.
Do not use FOLLITROPIN BETA if you are pregnant. You may need to have a negative pregnancy test before starting this treatment.
It is unknown whether FOLLITROPIN BETA is excreted in breast milk. Your healthcare provider should decide if you will take FOLLITROPIN BETA or breastfeed. You should not do both.
FOLLITROPIN BETA does not affect your ability to drive.
Limited information was available about using FOLLITROPIN BETA in patients with liver disease. Inform your doctor before receiving FOLLITROPIN BETA if you have a history of liver diseases. Your doctor will prescribe only if the benefits outweigh the risks.
Limited information was available about using FOLLITROPIN BETA in patients with kidney disease. Inform your doctor before receiving FOLLITROPIN BETA if you have a history of kidney diseases. Your doctor will prescribe only if the benefits outweigh the risks.
FOLLITROPIN BETA is not intended for use in children.
Consume a healthy diet rich in fibre and proteins and low in carbohydrates and fats.
Avoid processed or high-sugar foods.
Stay active and shed excess weight if you are overweight or obese. Do not perform intense exercises as they may negatively impact your reproductive health. Increase the intensity of exercise gradually.
Being underweight may also reduce your chances of getting pregnant. So, prepare a diet chart that can help you gain weight healthily.
Avoid stress, as it may decrease your chances of getting pregnant. Try relaxation techniques and receive support and counselling if necessary.
Limit alcohol and caffeine intake.
Quit smoking.
If you undergo a pregnancy test (blood or urine test) within ten days of using FOLLITROPIN BETA, there may be a chance of a false-positive test result.
Female Infertility: When a woman cannot become pregnant within a year of trying without the use of contraception, then the condition is called female infertility. If a woman gets pregnant but experiences miscarriages or stillbirths, it is also included in infertility. It can occur due to ovulation disorders (problems with ovaries), fallopian tube damage, and uterus or cervix problems. The risk factors can be age, being overweight or obese, smoking, alcoholism, and the presence of sexually transmitted infections.
Hypogonadism: It is a condition in which the gonads (testes in men and ovaries in women) produce insufficient sex hormones. Sex hormones are responsible for secondary sexual characteristics. This mainly occurs due to autoimmune disorders, genetic disorders, severe infections, pituitary disorders, and inflammatory diseases.